BERGISCH GLADBACH, Germany, June 27, 2013 /PRNewswire/ --
Miltenyi Biotec, the world's leading cell innovation company, announced today that it opened a new office in Seoul, Korea, enlarging the company's Asia-Pacific presence to six locations in five countries.
"Miltenyi Biotec recognizes the potential of a Korean presence in achieving strong, steady growth and expanding our global reach with a team of talented people," said CEO Boris Stoffel. "Our new team has an exceptional ability to partner with scientists and clinicians to generate exciting opportunities."
Daesuk Oh has been appointed General Manager of the new office in the Gangnam district of Seoul. "Our location will be instrumental in developing deeper relationships with a host of stem cell, immunology, translational research, and clinical customers, as well as prospective research and clinical institutions throughout South Korea. We're excited for the opportunity to bring Miltenyi Biotec's solutions to scientists and clinicians who can truly benefit from the quality and reliability the portfolio is known for," said Oh.
About Miltenyi Biotec
Miltenyi Biotec is a global provider of products and services that advance biomedical research. From research tools to GMP reagents, Miltenyi is making the promise of cell therapy a reality. The company's integrated portfolio of tools supports the translation of basic research into practical applications for human health. Scientists and clinicians around the world use Miltenyi-enabling technologies for effective sample preparation, cell isolation, flow cytometry, cell culture, molecular analysis and preclinical imaging. The MACS® brand has set standards in the industry and is trusted across basic, translational, and clinical research settings. The company also offers comprehensive technical support and training through its MACS® Academy. Miltenyi Biotec has 1,400 employees in 22 countries.
SOURCE Miltenyi Biotec GmbH